FDA Officials Place Stark Warning On Puberty Blockers For Minors

FDA Officials Place Stark Warning On Puberty Blockers For Minors


While the Biden administration does everything in its power to make medical gender transition surgeries more accessible for children, FDA officials warn about the potential negative side effects of puberty blockers for minors.

Earlier this month, the FDA placed a warning on puberty blockers because of brain swelling, loss of vision, and serious risks for children injecting the gonadotropin-releasing hormone (GnRH).

Per the organization, officials outlined a plausible association between the drug and pseudotumor cerebri, which displays symptoms similar to a brain tumor. These findings were identified in six young girls between the ages of 5 and 12.

Trending: RSBN to exclusively livestream True the Vote’s ‘The Pit’ which will reveal ‘devastating’ information about 2020

“Five were undergoing treatment for central precocious puberty and one for transgender care,” FDA officials reported. “The onset of pseudotumor cerebri symptoms ranged from three to

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend